These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 19880259

  • 21. Toxicity analysis of postoperative image-guided intensity-modulated radiotherapy for prostate cancer.
    Nath SK, Sandhu AP, Rose BS, Simpson DR, Nobiensky PD, Wang JZ, Millard F, Kane CJ, Parsons JK, Mundt AJ.
    Int J Radiat Oncol Biol Phys; 2010 Oct 01; 78(2):435-41. PubMed ID: 19939580
    [Abstract] [Full Text] [Related]

  • 22. Pilot study of conformal intensity modulated radiation therapy for localized prostate cancer.
    Aillères N, Azria D, Thézenas S, Barbier N, Fenoglietto P, Delard R, Hay MH, Dubois JB.
    Cancer Radiother; 2004 Apr 01; 8(2):59-69. PubMed ID: 15063872
    [Abstract] [Full Text] [Related]

  • 23. Role of intensity-modulated radiotherapy in reducing toxicity in dose escalation for localized prostate cancer.
    Al-Mamgani A, Heemsbergen WD, Peeters ST, Lebesque JV.
    Int J Radiat Oncol Biol Phys; 2009 Mar 01; 73(3):685-91. PubMed ID: 18718725
    [Abstract] [Full Text] [Related]

  • 24. Health-related quality of life in men after treatment of localized prostate cancer with external beam radiotherapy combined with (192)ir brachytherapy: a prospective study of 93 cases using the EORTC questionnaires QLQ-C30 and QLQ-PR25.
    Wahlgren T, Brandberg Y, Häggarth L, Hellström M, Nilsson S.
    Int J Radiat Oncol Biol Phys; 2004 Sep 01; 60(1):51-9. PubMed ID: 15337539
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Acute toxicity of whole-pelvis IMRT in 87 patients with localized prostate cancer.
    Sanguineti G, Endres EJ, Parker BC, Bicquart C, Little M, Chen G, Berilgen J.
    Acta Oncol; 2008 Sep 01; 47(2):301-10. PubMed ID: 18210303
    [Abstract] [Full Text] [Related]

  • 29. Image-guided dose-escalated intensity-modulated radiation therapy for prostate cancer: treating to doses beyond 78 Gy.
    Eade TN, Guo L, Forde E, Vaux K, Vass J, Hunt P, Kneebone A.
    BJU Int; 2012 Jun 01; 109(11):1655-60. PubMed ID: 22035373
    [Abstract] [Full Text] [Related]

  • 30. Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer.
    Zelefsky MJ, Chan H, Hunt M, Yamada Y, Shippy AM, Amols H.
    J Urol; 2006 Oct 01; 176(4 Pt 1):1415-9. PubMed ID: 16952647
    [Abstract] [Full Text] [Related]

  • 31. Phase II study of long-term androgen suppression with bevacizumab and intensity-modulated radiation therapy (IMRT) in high-risk prostate cancer.
    Vuky J, Pham HT, Warren S, Douglass E, Badiozamani K, Madsen B, Hsi A, Song G.
    Int J Radiat Oncol Biol Phys; 2012 Mar 15; 82(4):e609-15. PubMed ID: 22208976
    [Abstract] [Full Text] [Related]

  • 32. Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68 Gy to 78 Gy.
    Peeters ST, Heemsbergen WD, van Putten WL, Slot A, Tabak H, Mens JW, Lebesque JV, Koper PC.
    Int J Radiat Oncol Biol Phys; 2005 Mar 15; 61(4):1019-34. PubMed ID: 15752881
    [Abstract] [Full Text] [Related]

  • 33. Does treatment of the pelvic nodes with IMRT increase late rectal toxicity over conformal prostate-only radiotherapy to 76 Gy?
    Sanguineti G, Cavey ML, Endres EJ, Franzone P, Barra S, Parker BC, Marcenaro M, Colman M, Agostinelli S, Foppiano F, Vitale V.
    Strahlenther Onkol; 2006 Sep 15; 182(9):543-9. PubMed ID: 16944377
    [Abstract] [Full Text] [Related]

  • 34. Phase II trial of radiation dose escalation with conformal external beam radiotherapy and high-dose-rate brachytherapy combined with long-term androgen suppression in unfavorable prostate cancer: feasibility report.
    Valero J, Cambeiro M, Galán C, Teijeira M, Romero P, Zudaire J, Moreno M, Ciérvide R, Aristu JJ, Martínez-Monge R.
    Int J Radiat Oncol Biol Phys; 2010 Feb 01; 76(2):386-92. PubMed ID: 19427741
    [Abstract] [Full Text] [Related]

  • 35. Outcome and toxicity for patients treated with intensity modulated radiation therapy for localized prostate cancer.
    Vora SA, Wong WW, Schild SE, Ezzell GA, Andrews PE, Ferrigni RG, Swanson SK.
    J Urol; 2013 Aug 01; 190(2):521-6. PubMed ID: 23415964
    [Abstract] [Full Text] [Related]

  • 36. Salvage intensity-modulated radiotherapy for rising PSA after radical prostatectomy.
    De Meerleer G, Fonteyne V, Meersschout S, Van den Broecke C, Villeirs G, Lumen N, Ost P, Vandecasteele K, De Neve W.
    Radiother Oncol; 2008 Nov 01; 89(2):205-13. PubMed ID: 18771809
    [Abstract] [Full Text] [Related]

  • 37. The impact of acute urinary retention after iodine-125 prostate brachytherapy on health-related quality of life.
    Roeloffzen EM, Hinnen KA, Battermann JJ, Monninkhof EM, van Roermund JG, van Gellekom MP, Frank SJ, van Vulpen M.
    Int J Radiat Oncol Biol Phys; 2010 Aug 01; 77(5):1322-8. PubMed ID: 19939578
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Risk-adapted androgen deprivation and escalated three-dimensional conformal radiotherapy for prostate cancer: Does radiation dose influence outcome of patients treated with adjuvant androgen deprivation? A GICOR study.
    Zapatero A, Valcárcel F, Calvo FA, Algás R, Béjar A, Maldonado J, Villá S.
    J Clin Oncol; 2005 Sep 20; 23(27):6561-8. PubMed ID: 16170164
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.